ImClone Systems Inc (formerly IMCL)

[biophud]

Yeda Patent clarification/question. Base on my read, Imclone’s press release puts forth 2 contradictory ideas. Am I missing something?

1. Imclone disagrees with today’s decision and intends to appeal. These statements suggest that the patent has value and Imclone intends to fight for it.

2. ImClone Systems also believes that the consequence of the decision transferring inventorship to Yeda invalidates any claims in the patent under current patent law. Transfer of ownership invalidates the patent. These statements suggest that patent would have no value to Imclone or anyone else.

Any comment would be appreciated